Feb 27,2024 TOP STORY

Hedia Raises €3M Seed Extension to Expand Digital Health Portfolio

Hedia announced this week it has raised €3 million in a seed extension round strongly supported by existing shareholders and Business Angels. The new capital will enable Hedia's growth strategy and promising digital health product roadmap, continue to scale their Hedia Diabetes Assistant (HDA), as well as launching the Glooko- integrated holistic diabetes management solution later in the year.  Furthermore, the company will leverage its competencies in developing smart AI-enabled algorithms and Software-as-a-Medical Device (SaMD) solutions together with strategic partners within chronic metabolic diseases.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Mar 16,2021

Resilience Raises €5M To Accelerate the Development of Its Remote Patient Monitoring Platform in Oncology

Resilience is a new startup wants to help cancer treatment institutes as well as cancer patients at every step of the treatment journey. They recently raised a $6 million funding round (€5 million) led by Singular, the VC firm founded by former Alven partners Raffi Kamber and Jérémy Uzan. Tech business angels Nathalie Balla (La Redoute), Xavier Niel (Free), Jean-Charles Samuelian (Alan), Roxanne Varza (Station F) and more are also participating. There are also some healthcare investors in today’s funding round, such as Charles Ferté (AstraZeneca), Philippe Dabi (Bioclinic) and Thomas Clozel (Owkin). Resilience wants to become a full-stack software solution for cancer treatment for both the medical team and patients. When it comes to practitioners, Resilience will be a software-as-a-service solution that can augment therapeutic decisions. When it comes to patients, there will be a web and mobile app to access content and information about their cancer. In particular, Resilience could help you understand side effects and treat them.

FUNDING SEED ROUND

#rpm

View Analyst & Ambassador Comments
Go to original news
Jan 31,2024

Endocrinology company Valendo Health launches with $4M and two provider partners

Valendo Health, a diabetes-focused, value-based endocrinology company, announced its launch with $4 million in seed funding and two providers. The company, built out of Redesign Health, aims to increase revenue for endocrinologists while assisting with the transition to a value-based care model. It offers telehealth and remote patient monitoring services with diabetes care clinicians, an endocrinology-focused EMR, data analytics and assistance with implementing value-based care contracting. The Boston-based company has partnered with two providers: Cecelia Health, a national virtual specialty care provider for chronic care management, and Advanced Metabolic Care + Research, an endocrinology center in Southern California serving patients with diabetes and other metabolic conditions. "At Valendo, we provide endocrinologists the tools to increase clinical capacity and grow practice revenue through virtual care and practice management support, and then we help them transition into value-based contracts." said Dave Terry, CEO and cofounder of Valendo Health.

FUNDING SEED ROUND

#telehealth

#rpm

View Analyst & Ambassador Comments
Go to original news
Oct 31,2023

Egyptian health tech Almouneer raises $3.6M to scale its platform for treating diabetes and obesity

Almouneer, an Egyptian healthtech company, has raised $3.6 million in seed funding to support the development and expansion of its platform for treating diabetes and obesity. The funding round was led by Dubai-based Global Ventures, with participation from other international investors, including Proparco, Digital Africa via the Bridge Fund, Wrightwood Investments, and others. Almouneer’s platform, DRU, is a patient-centric, digitally-enabled lifestyle and diabetes management platform. It allows patients to upload their medical records, access their latest medical data and current medications, connect with doctors and healthcare personnel via chat or phone, and subscribe to personalised treatment and nutrition plans.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Dec 17,2019

TrialJectory Raises $3 Million in Seed Financing Round

TrialJectory (known as Leal Health now), an AI-powered technology platform that uses self-reported clinical data to match cancer patients with clinical trials and remove barriers to advanced treatment options, announced today that the Company has closed a $2.7 million seed financing round, led by Contour Venture Partners. Proceeds from the financing will expedite the growth of TrialJectory's platform, which includes adding more clinical trials for different cancer types and expanding the Company's outreach across the medical, pharmaceutical and patient communities. 

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Jul 01,2019

Hedia secured $2.3M in fresh new capital funding

Hedia, a Copenhagen, Denmark-based startup providing a digital solution for people suffering from diabetes, completed a DKK 15M ($2.3M) capital investment round. The funding was provided by Danish investors and will be used to support the company's expansion in the US market, expected in 2020.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Apr 18,2018

Feel Therapeutics Closes Seed Round to Change the Way We Manage Mental Health

Feel Therapeutics, Inc., a developer of artificial emotional intelligence technology that changes the way we monitor and manage mental health, today announced that it has raised a total of $1.8 million in seed funding from Anthemis Exponential Ventures, SOSV, Make in LA and angel investors.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Apr 17,2023

Perci Health raises £3.4 million to expand its digital cancer support platform

UK-based digital cancer support clinic, Perci Health has raised £3.4 million seed funding to expand cancer support services. The Seed round was led by Octopus Ventures. Chantel Cox, an investor with the Health team of Octopus ventures will join the Perci Health board. The Perci Health platform offers support to those living with and beyond cancer through personalised programmes. The programmes include support across the whole cancer continuum, from preparing for treatment to support during treatment, recovery and rehabilitation and return to work.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Aug 07,2019

SidekickHealth gets an injection from Novator

Novator, Björgólf Thor Björgólfsson's investment company, and related investors have completed a one hundred million ISK injection into the Icelandic health technology company SidekickHealth, but the investor group has contributed hundreds of millions to the company since its inception. SidekickHealth has one foot in the door of the global pharmaceutical industry after successfully partnering with two of the world's five largest pharmaceutical companies. A second and larger capital increase is planned for the end of the year.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Apr 16,2014

InSilico Medicine Receives Seed Funding from Deep Knowledge Ventures

InSilico Medicine, Inc. a Baltimore, Maryland-based developer of a drug knowledge management system of annotated drugs, small molecules, biologics available, received a seed funding from Deep Knowledge Ventures. Led by CEO Professor Alex Zhavoronkov, PhD, InSilico Medicine has been developing a comprehensive scalable drug knowledge management system of annotated drugs, small molecules, biologics available. The company aims to partner with top pharmaceutical companies to help analyze their drug databases and lead compounds, improve enrollment into clinical trials, and to enable them to accurately predict the efficacy of their drugs on patient groups and individual patients.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Subscribe to SEED ROUND